Clinical features and treatment effect of HIV-associated immune thrombocytopenia—single center Ten-Years data summary

References

• Duguma N, Tesfaye KG, Adissu MW, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: a cross-sectional study. SAGE Open Med. 2021;9:20503121211020175. doi:10.1177/20503121211020175.
   Google Scholar
• Morris L, Distenfeld A, Amorosi E, Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med. 1982;96(6_part_1):714–7. doi:10.7326/0003-4819-96-6-714.
   PubMed Web of Science ®Google Scholar
• Tamir Z, Seid A, Haileslassie H. Magnitude and associated factors of cytopenias among antiretroviral therapy naive human immunodeficiency virus infected adults in Dessie, Northeast Ethiopia. PLoS One. 2019;14(2):e0211708. doi:10.1371/journal.pone.0211708.
   PubMed Web of Science ®Google Scholar
• Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, Fryzek J, Kaye JA. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145(2):235–44. doi:10.1111/j.1365-2141.2009.07615.x.
   PubMed Web of Science ®Google Scholar
• Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol. 1992;48(3):168–72. doi:10.1111/j.1600-0609.1992.tb00591.x.
   PubMed Web of Science ®Google Scholar
• Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;52(5):595–9. doi:10.1097/QAI.0b013e3181b79aff.
   PubMed Web of Science ®Google Scholar
• Liebman HA. Viral-associated immune thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2008;2008(1):212–8. doi:10.1182/asheducation-2008.1.212.
   Google Scholar
• Mientjes GH, van Ameijden EJ, Mulder JW, Hoek JARVD, Coutinho RA, Borne AEVD. Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men. Br J Haematol. 1992;82(3):615–9. doi:10.1111/j.1365-2141.1992.tb06476.x.
   PubMed Web of Science ®Google Scholar
• Stasi R, Willis F, Shannon MS, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23(6):1275–97. doi:10.1016/j.hoc.2009.08.009.
   PubMed Web of Science ®Google Scholar
• Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998;91(1):301–8. doi:10.1182/blood.V91.1.301.
   PubMed Web of Science ®Google Scholar
• Burbano X, Miguez MJ, Lecusay R, Rodriguez A, Ruiz P, Morales G, Castillo G, Baum M, Shor-Posner G. Thrombocytopenia in HIV-infected drug users in the HAART era. Platelets. 2001;12(8):456–61. doi:10.1080/09537100120093956.
   PubMed Web of Science ®Google Scholar
• Wachtman LM, Skolasky RL, Tarwater PM, Esposito D, Schifitto G, Marder K, McDermott MP, Cohen BA, Nath A, Sacktor N, et al. Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia. Arch Neurol. 2007;64(9):1264–72. doi:10.1001/archneur.64.9.1264.
   PubMedGoogle Scholar
• Servais J, Nkoghe D, Schmit JC, Arendt V, Robert I, Staub T, Moutschen M, Schneider F, Hemmer R. HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28(3):221–5. doi:10.1097/00042560-200111010-00003.
   PubMed Web of Science ®Google Scholar
• Teh BS, Lu HH, Lynch GR, Banez E, Kroll MH. AIDS-related Kaposi’s sarcoma involving bone and bone marrow. South Med J. 1999;92(1):61–4. doi:10.1097/00007611-199901000-00012.
   PubMed Web of Science ®Google Scholar
• Who consolidated guidelines on hiv prevention: testing, treatment, service delivery and monitoring: recommendations for a public health approach; 2021.
   Google Scholar
• Liu XG, Bai XC, Chen FP, Cheng YF, Dai KS, Fang MY, Feng JM, Gong YP, Guo T, Guo XH, et al. Chinese guidelines for treatment of adult primary immune thrombocytopenia. Int J Hematol. 2018;107(6):615–23. doi:10.1007/s12185-018-2445-z.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–93. doi:10.1182/blood-2008-07-162503.
   PubMed Web of Science ®Google Scholar
• Ciernik IF, Cone RW, Fehr J, Weber R. Impaired liver function and retroviral activity are risk factors contributing to HIV-associated thrombocytopenia. Swiss HIV cohort study. Aids. 1999;13(14):1913–20. doi:10.1097/00002030-199910010-00014.
   PubMed Web of Science ®Google Scholar
• Grainger ST JD. A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia. Pediatr Hematol Oncol. 34(2), 73–89. doi:10.1080/08880018.2017.1313918.
   PubMed Web of Science ®Google Scholar
• Kowalczyk M, Rubinstein PG, Aboulafia DM. Initial experience with the use of thrombopoetin receptor agonists in patients with refractory HIV-Associated immune thrombocytopenic purpura: a case series. J Int Assoc Provid AIDS Care. 2015;14(3):211–6. doi:10.1177/2325957414557266.
   PubMedGoogle Scholar
• Talargia F, Getacher L. Thrombocytopenia and associated factors among HIV infected patients in pre- and post-anti-retroviral therapy, North East Ethiopia. J Blood Med. 2021;12:741–8. doi:10.2147/JBM.S323086.
   PubMed Web of Science ®Google Scholar
• Marchionatti A, Parisi MM. Anemia and thrombocytopenia in people living with HIV/AIDS: a narrative literature review. Int Health. 2021;13(2):98–109. doi:10.1093/inthealth/ihaa036.
   PubMed Web of Science ®Google Scholar
• Taylor KA, Smyth E, Rauzi F, Cerrone M, Khawaja AA, Gazzard B, Nelson M, Boffito M, Emerson M. Pharmacological impact of antiretroviral therapy on platelet function to investigate human immunodeficiency virus-associated cardiovascular risk. Br J Pharmacol. 2019;176(7):879–89. doi:10.1111/bph.14589.
   PubMed Web of Science ®Google Scholar
• Colebunders R, De Schacht C, Vanwolleghem T, Callens S. Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection. Int J Infect Dis. 2004;8(5):315–316.
   Google Scholar
• Li B, Zhang L, Liu Y, Xiao J, Wang X, Wei Y, Fan L, Duan Y, Li G, Kong Y, et al. Manifestations and related risk factors of thrombocyte abnormalities in HIV-Positive patients before and after the initiation of ART. Infect Drug Resist. 2021;14:4809–19. doi:10.2147/IDR.S334046.
   PubMed Web of Science ®Google Scholar
• Nka AD, Sosso SM, Fokam J, Bouba Y, Teto G, Simo Rachel R, Tiga A, Yimga J, Nukenine EN, Nanfack AJ, et al. Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé. BMC Res Notes. 2019;12(1):632. doi:10.1186/s13104-019-4664-7.
   PubMed Web of Science ®Google Scholar
• Wei Y, Ji XB, Wang YW, Wang J-X, Yang E-Q, Wang Z-C, Sang Y-Q, Bi Z-M, Ren C-A, Zhou F, et al. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016;127(3):296–302; quiz 370. doi:10.1182/blood-2015-07-659656.
   PubMed Web of Science ®Google Scholar
• Bettaieb A, Fromont P, Louache F, Oksenhendler E, Vainchenker W, Duedari N, Bierling P. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992;80(1):162–9. doi:10.1182/blood.V80.1.162.162.
   PubMed Web of Science ®Google Scholar
• Costantini A, Giuliodoro S, Mancini S, Butini L, Regnery CM, Silvestri G, Greco F, Leoni P, Montroni M. Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication. Aids. 2006;20(13):1713–20. doi:10.1097/01.aids.0000242817.88086.8c.
   PubMed Web of Science ®Google Scholar
• Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48(6):1000–7. doi:10.1016/j.jhep.2008.03.009.
   PubMed Web of Science ®Google Scholar
• MSKA IL. The comparative analysis of morphological structre of a liver in patients with HIV-HCV coninfection and HCV-monoinfection in Russia. 16th International AIDS Conference; 2006; Toronto Canada.
   Google Scholar
• Basharkhah S, Sabet F, Ghezeldasht SA, Mosavat A, Jahantigh HR, Barati E, Shamsian K, Saleh‐moghaddam M, Sharebyani H, Hassannia T, et al. Prediction of HCV load using genotype, liver biomarkers, and clinical symptoms by a mathematical model in patients with HCV infection. Microbiol Immunol. 2019;63(11):449–57. doi:10.1111/1348-0421.12735.
   PubMed Web of Science ®Google Scholar